Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Particle Size Analysis in MDIs

Posted on By

SOP for Particle Size Analysis in MDIs

MDI Particle Size Analysis Procedures

1) Purpose

The purpose of this SOP is to establish the procedures for particle size analysis of metered-dose inhalers (MDIs) to ensure proper aerosol performance and drug delivery efficiency.

2) Scope

This SOP applies to all personnel involved in the particle size analysis of MDIs at the manufacturing facility, including laboratory technicians and quality control staff.

3) Responsibilities

The responsibilities for this SOP include performing particle size analysis accurately, documenting results, and ensuring compliance with regulatory standards. Specific roles include:
Laboratory Technicians: Conduct particle size analysis as specified.
Quality Control Staff: Review and document the results of particle size analysis.

See also  SOP for Analytical Method Development for MDIs

4) Procedure

4.1 Sample Preparation
4.1.1 Collect MDI samples from each batch following the sampling plan.
4.1.2 Ensure samples are properly labeled and stored prior to analysis.
4.2 Equipment Setup
4.2.1 Set up the particle size analyzer according to the manufacturer’s instructions.
4.2.2 Calibrate the equipment using standard reference materials.
4.3 Analysis Procedure
4.3.1 Prepare the MDI sample for analysis by shaking or priming as necessary.
4.3.2 Introduce the sample into the particle

size analyzer.
4.3.3 Record the particle size distribution data.
4.3.4 Perform multiple analyses to ensure consistency and accuracy.
4.4 Data Recording
4.4.1 Document all particle size distribution results in the analysis logbook.
4.4.2 Ensure data integrity and compliance with Good Laboratory Practice (GLP) guidelines.
4.5 Review and Analysis
4.5.1 Analyze the particle size data to ensure it meets acceptance criteria.
4.5.2 Review results and prepare a particle size analysis report.
4.6 Reporting
4.6.1 Submit particle size analysis reports to the quality assurance department for approval.
4.6.2 Update the particle size analysis schedule as required.

See also  SOP for Formulation Development for MDIs

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
GLP: Good Laboratory Practice

6) Documents, if any

Particle size analysis logs, equipment calibration records, and analysis reports should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for particle size analysis standards.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: Powder & Granules: SOP for Stability Testing of Granules
Next Post: Vaginal Dosage Forms: SOP for Gel Homogenizer

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version